Fewer Cancer Trials Launched During First Wave of COVID-19 Pandemic

NEW YORK (Reuters Health) – The number of oncology clinical trials that launched globally during the first half of 2020 declined by 60% as compared with previous years, according to a new study. The findings add to evidence that the pandemic may have long-term indirect effects on cancer treatments, drug development and new therapies, researchers write in JAMA Network Open. […]
» Read more